Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma
Despite recent advances in therapy, liver metastasis from melanoma is still associated with poor prognosis. Although targeting the mTOR signaling pathway exerts potent anti-tumor activity, little is known about specific mTORC2 inhibition regarding liver metastasis. Using the novel mTORC2 specific in...
Main Authors: | Jessica Guenzle, Harue Akasaka, Katharina Joechle, Wilfried Reichardt, Aina Venkatasamy, Jens Hoeppner, Claus Hellerbrand, Stefan Fichtner-Feigl, Sven A. Lang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/1/30 |
Similar Items
-
mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
by: Jin Young Yang, et al.
Published: (2019-06-01) -
mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system
by: Linqing Miao, et al.
Published: (2016-03-01) -
Pathological Consequences of Hepatic mTORC1 Dysregulation
by: Chun-Seok Cho, et al.
Published: (2020-08-01) -
LPS Induces mTORC1 and mTORC2 Activation During Monocyte Adhesion
by: Marcelle C. Ribeiro, et al.
Published: (2018-07-01) -
A Positive Feedback Loop between Sestrin2 and mTORC2 Is Required for the Survival of Glutamine-Depleted Lung Cancer Cells
by: Jun-Kyu Byun, et al.
Published: (2017-07-01)